Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protective Effects of Edaravone Dexborneol in Acute Ischemic Stroke
NCT05024526Unknown
- Start
- Apr 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of edaravone dexborneol in ischemic stroke (2 arms). Primary endpoint: Changes in ischemic penumbra and collateral circulation at 7 days. Status: unknown.
02
Drugs
edaravone dexborneol
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05024526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05024526.